THE CHINWAGY BUZZ · FIRST VERIFIED WORD
Merck and Daiichi Sankyo continue global ADC collaboration

WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
Merck confirmed its continuing global collaboration with Daiichi Sankyo to jointly develop and commercialize multiple antibody-drug conjugates, expanded in 2024 to include gocatamig.
- Current status
- Official collaboration
- Known availability
- The official source confirms the collaboration; timing details remain under review.
- Place
- International, Global
- Source checked
- September 15, 2026
FOLLOW THE STORY